tiprankstipranks
Armata Pharmaceuticals Announces CMO Departure Agreement
Company Announcements

Armata Pharmaceuticals Announces CMO Departure Agreement

Pick the best stocks and maximize your portfolio:

Armata Pharmaceuticals ( (ARMP) ) has shared an update.

Armata Pharmaceuticals has reached a separation agreement with its Chief Medical Officer, Dr. Mina Pastagia, effective November 13, 2024. Dr. Pastagia will receive her base salary for 12 months in exchange for releasing claims against the company, contingent on her compliance with the agreement terms.

Learn more about ARMP stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskArmata Pharmaceuticals Extends Credit Agreement and CMO Departs
TheFlyArmata Pharmaceuticals reports Q3 EPS (15c) vs. (86c) last year
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App